Melanoma to rhabdomyosarcoma plasticity in the setting of immunotherapy
Andrew Knight(Harvard University), Arnav Mehta(California Institute of Technology), Ivan Chebib(Massachusetts General Hospital), Keith T. Flaherty(Cancer Research Center), Tatyana Sharova(Harvard University), John H. Shin(Penn Center for AIDS Research), Alvin Shi(Broad Institute), Emily Robitschek(Broad Institute), Ana Belén Larque(Massachusetts General Hospital), Genevieve M. Boland(Harvard University), Dennie T. Frederick(Broad Institute), Nir Hacohen(Cambridge Hospital), Jia‐Ren Lin(Harvard University), Rumya Raghavan(Broad Institute), Peter K. Sorger(Harvard University Press), Ryan J. Sullivan(Harvard University), Manolis Kellis(Broad Institute), David Liu(University of Louisville), Benchun Miao(Massachusetts General Hospital)
Cited by 0
Related Papers
Full-length transcriptome assembly from RNA-Seq data without a reference genome
|Nature Biotechnology|2011|22.7k
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
|Science|2016|5.3k
Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals
|Nature|2009|4.2k
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
|New England Journal of Medicine|2010|3.5k